一分钟看懂
这是一项关于乳腺癌的III 期研究，登记的药物或干预包括TQB2102 for Injection；Chemotherapy drug (Capecitabine/Paclitaxel/Albumin Paclitaxel)，当前状态为研究进行中，已停止招募。登记地点显示中国蚌埠、合肥、北京、泉州等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
TQB2102 for Injection；Chemotherapy drug (Capecitabine/Paclitaxel/Albumin Paclitaxel) · III 期
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- The First Affiliated Hospital of Bengbu Medical University · 蚌埠
- AnHui Province Hospital West District · 合肥
- The first Affiliated hospital of anhui medical university · 合肥
- Beijing Cancer Hospital · 北京
- Fujian Medical University 2nd Affiliated Hospital · 泉州
- Zhangzhou Hospital in Fujian Province · 漳州
- Gansu Provincial Hospital · 兰州
- Gansu Provincial Cancer Hospital · 兰州
- Gansu Wuwei Tumour Hospital · 武威
- Sun Yet-Sen University Cancer Certer · 广州
- Affiliated Hospital of Guangdong Medical University · 湛江
- Guigang City People'S Hospital · 贵港
- Cancer Hospital Affiliated to Guangxi Medical University · 南宁
- The First affiliated hospital of GuangXi medical university · 南宁
- The Affiliated Cancer Hospital of Guizhou Medical University Co., LTD · 贵阳
- Guizhou Provincial People's Hospital · 贵阳
- The First Affiliated Hospital of Hainan Medical College · 海口
- Hainan General Hospital · 海口
- Affiliated Hospital of Hebei University · 保定
- Chengde Central Hospital · 承德
- Affiliated Cancer Hospital of Harbin Medical University · 哈尔滨
- AnYang Tumor Hospital · 安阳
- Henan Cancar Hospital · 郑州
- The First Affiliated Hospital of Henan University of Science & Technology · 洛阳
- Tongji Hospital Tongji Medical College of HUST · 武汉
- Hubei Cancer Hospital · 武汉
- Chifeng Municipal Hospital · 赤峰
- The Second Hospital of DALIAN Medical University · 大连
- Binzhou Medical College Affiliated Hospital · 滨州
- Binzhou People's Hospital · 滨州
- Obstetrics & Gynecology Hospital of Fudan University · 上海
- Baoji Central Hospital · 宝鸡
- Affiliated Hospital of North Scichuan Medical College · 南充
- Affiliated Hangzhou First People's Hospital · 杭州
公开的入选条件
- * Subjects voluntarily enrolled in this study with good compliance;
- * Age: 18-75 years old; Eastern Cooperative Oncology Group Performance Status (ECOG PS) score: 0-1;
- * Pathologically confirmed locally advanced or metastatic breast cancer with low HER2 expression and unresectable:
- * Defined hormone receptor (HR) status.
- * Imaging-confirmed disease progression (during or after completion of the most recent treatment);
- * Have at least one measurable lesion according to RECIST 1.1 criteria;
- * Good major organ function.
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT06561607；登记信息更新于 2026-09-10。